The stock of 22nd Century Group Incorporated (NYSEMKT:XXII) registered a decrease of 25.03% in short interest. XXII’s total short interest was 1.91M shares in March as published by FINRA. Its down 25.03% from 2.55M shares, reported previously. With 504,200 shares average volume, it will take short sellers 4 days to cover their XXII’s short positions. The short interest to 22nd Century Group Incorporated’s float is 3.79%. The stock decreased 2.81% or $0.028 on March 4, hitting $0.952. About 261,781 shares traded hands. 22nd Century Group Inc (NYSEMKT:XXII) has risen 27.07% since July 30, 2015 and is uptrending. It has outperformed by 32.22% the S&P500.
22nd Century Group, Inc. is a plant biotechnology firm specializing in technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding. The company has a market cap of $70.37 million. The Firm is focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It currently has negative earnings. It owns and controls around 128 issued patents and an additional 52 pending patent applications.
The institutional sentiment decreased to 0.55 in 2015 Q3. Its down 0.23, from 0.78 in 2015Q2. The ratio turned negative, as 14 funds sold all 22nd Century Group Inc shares owned while 8 reduced positions. 8 funds bought stakes while 4 increased positions. They now own 7.05 million shares or 102.98% more from 3.47 million shares in 2015Q2.
Strategic Advisors Llc holds 0.03% of its portfolio in 22nd Century Group Inc for 49,250 shares. Courier Capital Corp owns 34,780 shares or 0.01% of their US portfolio. Moreover, San Francisco Sentry Investment Group (Ca) has 0.01% invested in the company for 11,650 shares. The Pennsylvania-based Vanguard Group Inc has invested 0.01% in the stock. American International Group Inc, a New York-based fund reported 46,500 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
